Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Frasers Group appoints Jon Thompson as new chair as Daly steps down

(Sharecast News) - Frasers Group said on Friday that chair David Daly will step down from the board at the annual general meeting next month after eight years of service and will be succeeded by Sir Jon Thompson on 1 September. The company also said it expects to appoint Andy Lyon as non-executive director and to make a further announcement in due course regarding a second, "well-advanced" candidate, for a further non-executive director position.

Those roles would succeed David Daly, Ger Wright and Helen Wright, who are not seeking re-election at the forthcoming AGM.

Thompson joined the group's board of directors in June 2024 as a non-executive director, "bringing with him extensive experience in corporate governance and major project management," Frasers said.

"His appointment marks an important step in supporting Frasers Group's long-term strategy as it continues to strengthen its position as a global business," it added.

Frasers said that Andy Lyon, a former partner at PwC whose expertise includes acting as audit partner for Next and its credit business, "would add significant financial and governance experience to further strengthen the team as it develops Frasers Plus".

Chief executive Michael Murray said: "I would like to thank David for his outstanding leadership, guidance, and the wealth of expertise he brought to the board, which has been instrumental in helping us deliver on our Elevation Strategy. We wish him all the very best for the future. I would also like to thank Ger and Helen for their contributions during their time with Frasers Group.

"I'm equally delighted to announce our proposed new appointment to the board with Andy, as well as Jon's confirmed appointment to chair, as we enter the next phase of our strategy. Jon's deep experience in corporate governance and strategic leadership will be invaluable as we continue to grow as a leading global retail business."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.